- Home
- SANA vs BLFS Comparison
SANA vs BLFS Comparison
Compare SANA & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SANA | BLFS |
|---|---|---|
| Founded | 2018 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2021 | 2013 |
Fundamental Metrics
Financial Performance| Metric | SANA | BLFS |
|---|---|---|
| Price | $4.18 | $22.65 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | $7.83 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 1.8M | 391.5K |
| Earning Date | 01-01-0001 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 20.55 | ★ 77.27 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $96,214,000.00 |
| Revenue This Year | N/A | $17.74 |
| Revenue Next Year | N/A | $21.62 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 16.97 |
| 52 Week Low | $1.27 | $19.15 |
| 52 Week High | $6.55 | $29.57 |
Technical Indicators
Market Signals| Indicator | SANA | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 49.20 | 46.14 |
| Support Level | $3.93 | $20.54 |
| Resistance Level | $4.39 | $23.00 |
| Average True Range (ATR) | 0.23 | 0.95 |
| MACD | 0.04 | 0.15 |
| Stochastic Oscillator | 62.00 | 29.21 |
Price Performance
Historical ComparisonAbout SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.